Jubilant Pharmova Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 235.20 | 214.40 | 209.50 |
| Operating Expense | 191.30 | 185 | 171.80 |
| Net Profit | 13.60 | 5.30 | 10.50 |
| Net Profit Margin | 5.78 | 2.47 | 5.01 |
| Earning Per Share | 0.86 | 0.33 | 0.66 |
| EBIDTA | 42.20 | 32.30 | 36.90 |
| Effective Tax Rate | 18.68 | 21.43 | 14.06 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 235.20 |
| Operating Expense | 191.30 |
| Net Profit | 13.60 |
| Net Profit Margin | 5.78 |
| Earning Per Share | 0.86 |
| EBIDTA | 42.20 |
| Effective Tax Rate | 18.68 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 784.70 | 810.10 | 87.75 |
| Operating Expenses Annual | 768.20 | 807 | 94.54 |
| Operating Profit Annual | 119.90 | 141 | 119.08 |
| Interest Annual | 29.90 | 18.50 | 30.59 |
| Depreciation | 36.60 | 34.30 | 2.84 |
| Net Profit Annual | 31.60 | 49.90 | 78.50 |
| Tax Annual | 10.10 | 29.40 | 3.75 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 784.70 |
| Operating Expenses Annual | 768.20 |
| Operating Profit Annual | 119.90 |
| Interest Annual | 29.90 |
| Depreciation | 36.60 |
| Net Profit Annual | 31.60 |
| Tax Annual | 10.10 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 11 | 22.50 | 40.33 |
| Cash Flow from Operations | 143.20 | -65.10 | -3.55 |
| Cash Flow from Investing | -40.30 | 31.10 | 93.10 |
| Cash Flow from Financing | -77.80 | 22.50 | -107.37 |
| Cash Flow at the End | 36.10 | 11 | 22.51 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 11 |
| Cash Flow from Operations | 143.20 |
| Cash Flow from Investing | -40.30 |
| Cash Flow from Financing | -77.80 |
| Cash Flow at the End | 36.10 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 15.28 | 17.41 | 135.72 |
| PBIT Margin (%) | 9.12 | 12.07 | 128.59 |
| PBT Margin (%) | 8.82 | 11.42 | 124.38 |
| Net PROFIT Margin (%) | 4.03 | 6.16 | 89.46 |
| Return On Networth / Equity (%) | 1.32 | 2.70 | 6.12 |
| Return On Networth /Employed (%) | 2.57 | 4.27 | 6.29 |
| Return On Assets (%) | 1.13 | 2.16 | 4.47 |
| Total Debt / Equity (X) | 0.15 | 0.23 | 0.39 |
| Asset Turnover Ratio (%) | 0.28 | 0.35 | 0.05 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 15.28 |
| PBIT Margin (%) | 9.12 |
| PBT Margin (%) | 8.82 |
| Net PROFIT Margin (%) | 4.03 |
| Return On Networth / Equity (%) | 1.32 |
| Return On Networth /Employed (%) | 2.57 |
| Return On Assets (%) | 1.13 |
| Total Debt / Equity (X) | 0.15 |
| Asset Turnover Ratio (%) | 0.28 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 711.30 | 687.40 | 123.54 |
| Total Current Assets Annual | 540.60 | 578.80 | 47.90 |
| Non Current Assets Annual | 2,451.30 | 2,429.60 | 1,781.57 |
| Total Shareholders Funds Annual | 2,374.50 | 2,414.50 | 1,281.82 |
| Total Assets Annual | 2,991.90 | 3,008.40 | 1,829.47 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 711.30 |
| Total Current Assets Annual | 540.60 |
| Non Current Assets Annual | 2,451.30 |
| Total Shareholders Funds Annual | 2,374.50 |
| Total Assets Annual | 2,991.90 |
EPS (INR)
Expected
9.72
Reported
9.71
Surprise
-0.10%
Dec 2024
EPS beaten by -0.10%
Sep 2024
EPS beaten by -0.31%
Jun 2024
EPS beaten by -0.61%
